advertisement

Topcon

Weinreb R 10

Showing records 1 to 10 | Display all abstracts from Weinreb R

74692 High-precision piezo-ejection ocular microdosing: Phase II study on local and systemic effects of topical phenylephrine
Ianchulev T
Therapeutic delivery 2018; 9: 17-27
74825 Comparison of macular choroidal thickness in patients with pseudoexfoliation syndrome to normal control subjects with enhanced depth SD-OCT imaging
Moghimi S
Journal of current ophthalmology 2017; 29: 258-263
74692 High-precision piezo-ejection ocular microdosing: Phase II study on local and systemic effects of topical phenylephrine
Weinreb R
Therapeutic delivery 2018; 9: 17-27
74825 Comparison of macular choroidal thickness in patients with pseudoexfoliation syndrome to normal control subjects with enhanced depth SD-OCT imaging
Mazloumi M
Journal of current ophthalmology 2017; 29: 258-263
74692 High-precision piezo-ejection ocular microdosing: Phase II study on local and systemic effects of topical phenylephrine
Tsai JC
Therapeutic delivery 2018; 9: 17-27
74825 Comparison of macular choroidal thickness in patients with pseudoexfoliation syndrome to normal control subjects with enhanced depth SD-OCT imaging
Johari MK; Fard MA
Journal of current ophthalmology 2017; 29: 258-263
74692 High-precision piezo-ejection ocular microdosing: Phase II study on local and systemic effects of topical phenylephrine
Lin S
Therapeutic delivery 2018; 9: 17-27
74825 Comparison of macular choroidal thickness in patients with pseudoexfoliation syndrome to normal control subjects with enhanced depth SD-OCT imaging
Chen R
Journal of current ophthalmology 2017; 29: 258-263
74692 High-precision piezo-ejection ocular microdosing: Phase II study on local and systemic effects of topical phenylephrine
Pasquale LR
Therapeutic delivery 2018; 9: 17-27
74825 Comparison of macular choroidal thickness in patients with pseudoexfoliation syndrome to normal control subjects with enhanced depth SD-OCT imaging
Weinreb R; Nouri-Mahdavi K
Journal of current ophthalmology 2017; 29: 258-263

Issue 19-1

Change Issue


advertisement

Oculus